Related Experiment Video

Updated: Jan 21, 2026

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.4K

Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors

Minas P Economides1, Srdan Verstovsek2, Naveen Pemmaraju3

  • 1Department of Internal Medicine, The University of Texas School of Health Sciences at Houston, Houston, TX, USA.

Current Hematologic Malignancy Reports
|August 3, 2019
PubMed
Abstract

Insights

New targeted agents are being developed for myeloproliferative neoplasms (MPNs) beyond current treatments like ruxolitinib. These novel therapies address unmet needs in MPN treatment by targeting various molecular pathways and cellular mechanisms.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Myeloproliferative neoplasms (MPNs) are a group of blood cancers with evolving treatment landscapes.
  • Ruxolitinib has improved outcomes for myelofibrosis but has limitations in efficacy and tolerability for some patients.

Purpose of the Study:

  • To review current treatment options for MPNs.
  • To discuss novel targeted agents under investigation for MPNs.

Main Methods:

  • Comprehensive review of preclinical data and clinical trials.
  • Summary of novel agents targeting various molecular pathways.

Main Results:

  • Ruxolitinib offers benefits but does not benefit all MPN patients.
  • Novel agents target apoptosis, tumor microenvironment, telomerase, and fibrosis.
  • Investigational agents are being evaluated alone or in combination with ruxolitinib.

Conclusions:

  • Understanding MPN pathobiology drives the development of new therapeutic strategies.
  • Novel targeted agents show promise for improving MPN treatment outcomes.
Keywords:
JAK inhibitorsMyeloproliferative neoplasmsNovel drugsNovel therapiesRuxolitinib

More Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.2K
Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors05:46

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors

Published on: June 27, 2025

552

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
375
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
608
Psychodynamic Therapy01:29

Psychodynamic Therapy

Psychodynamic therapies emphasize the exploration of unconscious processes and early childhood experiences as fundamental contributors to psychological difficulties. These therapies, deeply rooted in Freud's psychoanalytic theory, aim to uncover and resolve unconscious conflicts, granting individuals insights that promote emotional and behavioral healing. Contemporary psychodynamic approaches have evolved, integrating a broader range of influences and methodologies while still valuing the...
525